Prediction of response to anti-cancer drugs becomes robust via network integration of molecular data

Despite the widening range of high-throughput platforms and exponential growth of generated data volume, the validation of biomarkers discovered from large-scale data remains a challenging field. In order to tackle cancer heterogeneity and comply with the data dimensionality, a number of network and...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco, Marcela, Jeggari, Ashwini, Peuget, Sylvain, Böttger, Franziska, Selivanova, Galina, Alexeyenko, Andrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382934/
https://www.ncbi.nlm.nih.gov/pubmed/30787419
http://dx.doi.org/10.1038/s41598-019-39019-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382934/
https://www.ncbi.nlm.nih.gov/pubmed/30787419
http://dx.doi.org/10.1038/s41598-019-39019-2

Ejemplares similares